Net Medical Xpress Solutions, Inc. engages in the provison of solutions for the telemedicine industry. The company is headquartered in Albuquerque, New Mexico. The company went IPO on 2000-11-22. The firm is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. The company focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. The company offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
根据最新的财务报表(Form-10K),Net Medical Xpress Solutions Inc 的总资产为 $0,净损失为 $0
NMXS 的关键财务比率是什么?
Net Medical Xpress Solutions Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Net Medical Xpress Solutions Inc 的收入按细分市场或地理位置如何划分?
Net Medical Xpress Solutions Inc 最大收入来源是 Physician Services/Technical Services,在最近的收益报告中收入为 480,000。就地区而言, United States 是 Net Medical Xpress Solutions Inc 的主要市场,收入为 597,000。
Net Medical Xpress Solutions Inc 是否盈利?
不,根据最新的财务报表,Net Medical Xpress Solutions Inc 的净损失为 $0